Project description DEENESFRITPL ECG patch to speed up detection of cardiac arrhythmia Cardiovascular disease has been attributed to 31 % of all global deaths. Holter systems for electrocardiogram (ECG) monitoring are usually used for early disease detection and medical intervention but over 80 % of cardiac arrhythmias cannot be detected by these systems. Through the HeartService project, a patient will wear a patch containing an ECG monitor that provides accurate and timely data to a service centre for diagnosis by cardiologists. The cost-effective patch and data services will be introduced in 2019, while the grant will be used to determine best strategies for the product’s dissemination in EU countries. Show the project objective Hide the project objective Objective Cardiovascular disease (CVD) takes the lives of 17.9 million people every year, representing 31% of all global deaths. Early recognition and detection of CVDs is crucial for a patient’s chance of survival. CVD can be discovered by prolonged electrocardiogram (ECG) monitoring. Unfortunately, the chance to detect cardiac arrhythmias with the commonly used Holter systems is less than 20%. In addition, the delay between doctor visit and diagnosis is long (2 weeks), due to waiting lists in hospitals and a lack of Holter devices and resources for analysis. There is a need for cost-effective solutions for ECG monitoring to enable efficient and timely screening of patients with suspected heart problems. Glanum Medical is a Dutch start-up company developing a small ECG monitor integrated in a patch as a ground-breaking solution that will enable early diagnoses of cardiac patients. This novel ECG patch is accurate, affordable and patient friendly as compared to conventional Holter systems. The company launches a supporting diagnostic service center for centralized diagnosis by cardiologists. Glanum Medical will provide the infrastructure for distribution and collection of the ECG patch data analysis. As such, the company empowers medical doctors to offer fast, cost-effective and high-quality ECG-based diagnosis.Glanum will introduce its ECG patch and diagnostic services in 2019 at the Dutch market as a showcase of their product. The company has the ambition to rapidly scale-up to the EU market and will use the SME Phase 1 grant to identify the optimal business strategy for exploitation of its product and service in different EU countries. The feasibility study includes analysis of EU healthcare systems, reimbursement strategies, stakeholder needs and market acceptance to facilitate large-scale roll-out from 2021. Fields of science natural sciencescomputer and information sciencesdata sciencemedical and health sciencesclinical medicinecardiologycardiovascular diseasescardiac arrhythmiasocial sciencessociologydemographymortalitysocial scienceseconomics and businessbusiness and managementbusiness models Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-1 Funding Scheme SME-1 - SME instrument phase 1 Coordinator GLANUM MEDICAL BV Net EU contribution € 50 000,00 Address NOORD BRABANTLAAN 265 5652 LD EINDHOVEN Netherlands See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00
